Jamieson Wellness Inc. (OTCMKTS:JWLLF – Get Free Report) saw a significant decline in short interest in the month of August. As of August 14th, there was short interest totaling 94,875 shares, a decline of 76.6% from the July 30th total of 404,709 shares. Based on an average daily trading volume, of 6,636 shares, the days-to-cover ratio is currently 14.3 days.
Jamieson Wellness Price Performance
Shares of Jamieson Wellness stock remained flat at $32.91 during trading on Thursday. The company had a trading volume of 500 shares, compared to its average volume of 5,178. Jamieson Wellness has a 12 month low of $23.88 and a 12 month high of $33.15. The stock has a 50-day simple moving average of $30.11 and a 200-day simple moving average of $27.07.
Wall Street Analysts Forecast Growth
A number of equities analysts have issued reports on JWLLF shares. National Bank Financial reiterated an “outperform” rating on shares of Jamieson Wellness in a report on Friday, June 26th. Canadian Imperial Bank of Commerce reaffirmed an “outperform” rating on shares of Jamieson Wellness in a research report on Friday, May 8th. Royal Bank Of Canada lowered shares of Jamieson Wellness from an “outperform” rating to a “sector perform” rating in a research note on Monday, August 10th. Finally, Citigroup lowered shares of Jamieson Wellness to a “hold” rating in a research note on Friday, August 7th. Two equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy”.
About Jamieson Wellness
Jamieson Wellness is a leading Canadian manufacturer and distributor of nutraceutical products, including vitamins, minerals, herbal remedies and dietary supplements. Founded in 1922, the company has grown to offer a diverse portfolio of formulations designed to support general health, immune function, digestion and other specialized wellness needs. Its flagship Jamieson brand is complemented by sub-brands such as bkind, reflecting a commitment to innovation and consumer choice across a range of tablet, capsule and gummy formats.
The company serves both domestic and international markets through a multi-channel approach that includes major mass and drug retailers, specialty stores and direct-to-consumer e-commerce platforms.
Recommended Stories
- Five stocks we like better than Jamieson Wellness
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
- Permian Resources Rally Faces a Test
- Google Cloud Just Gave Rezolve AI a Major Vote of Confidence
Receive News & Ratings for Jamieson Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jamieson Wellness and related companies with MarketBeat.com's FREE daily email newsletter.
